Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer

Prostate Cancer and Prostatic Diseases volume 9, pages 275–278 (2006)Cite this article

Abstract

Purpose: Hot flash (HF) is a common side effect in prostate cancer patient undergoing androgen-deprivation therapy (ADT). In this study, we evaluated the efficacy of paroxetine (selective serotonin reuptake inhibitors (SSRIs)) for HF.

Patients and methods: In total, 10 men with prostate cancer under ADH who were suffering with HF entered this study. Self-report questionnaire was used for the evaluation.

Results: The average rating for HF frequency decreased (P=0.009) and HF severity decreased (P=0.0332) also, reported QOL score increased (P=0.0218).

Conclusion: These preliminary data suggest that low dose (10 mg/day) of antidepressant paroxetine can be helpful in the treatment of HFs in patients under ADT for prostate cancer. Further controlled studies are needed to more fully evaluate the efficacy of the SSRIs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Karling P, Hammar M, Varenhorst E . Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. J Urol 1994; 152: 1170–1173.

    Article  CAS  Google Scholar 

  2. Kronenberg F . Hot flashes: Phenomenology. Quality of life, and search for treatment options. Exp Gerontol 1994; 29: 319–336.

    Article  CAS  Google Scholar 

  3. Loprinzi CL, Barton DL, Carpenter LA, Sloan JA, Novotny PJ, Guttman MT et al. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc 2004; 79 (10): 1247–1251.

    Article  CAS  Google Scholar 

  4. Swartzman LC, Edelberg R, Kemmann E . The menopausal hot flush:symptom reports and concomitant physiological changes. J Behav Med. 1990; 13: 15–30.

    Article  CAS  Google Scholar 

  5. Charig CR, Rundle JS . Flushing. Long-term side effects of orchidectomy in treatment of prostatic cancer. Urology 1989; 33: 175.

    Article  CAS  Google Scholar 

  6. Frodin T, Alund G, Varenhorst E . Measurement of skin blood flow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patient with prostatic cancer. Prostate 1985; 7: 203–208.

    Article  CAS  Google Scholar 

  7. Sarosdy MF, Schellhammer PF, Soloway MS, Vogelzang NJ, Crawford ED, Presti J et al. Endocrine effect, efficacy and tolerability of a 10.8 mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer. BJU Int 1999; 83: 801–806.

    Article  CAS  Google Scholar 

  8. Parmar H, Edwards L, Phillips RH, Allen L, Lightman SL . Orchidectomy versus long acting D-Trip-6-LHRH in advanced prostate cancer. Br J Urol 1987; 59: 248–254.

    Article  CAS  Google Scholar 

  9. Beckman AL . Effect of intrahypothalamic norepinephrine on thermoregulatory responses in the rat. Am J Physiol 1970; 218: 1596–1604.

    Article  CAS  Google Scholar 

  10. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL . Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002; 77: 1207–1218.

    Article  CAS  Google Scholar 

  11. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998; 16: 495–500.

    Article  CAS  Google Scholar 

  12. Lebherz TB, French L . Nonhormonal treatment of the menopausal syndrome. A double-blind evaluation of an autonomic system stabilizer. Obstet Gynecol 1969; 33: 795–799.

    CAS  PubMed  Google Scholar 

  13. Goldberg RM, Loprinzi CL, O'Fallon JR, Veeder MH, Miser AW, Mailliard JA et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1996; 14 (8): 2411.

    Article  Google Scholar 

  14. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini F, DeAloysio D . The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998; 91: 6–11.

    Article  CAS  Google Scholar 

  15. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, La Vasseur BI, Barton DL et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000; 356: 2025–2026.

    Article  Google Scholar 

  16. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20: 1578–1583.

    Article  CAS  Google Scholar 

  17. Pandya KJ, Morrow GR, Roscoe JA, Zhao JA, Hickok JT, Pajon E et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial. Lancet 2005; 3–9; 366 (9488): 818–824.

    Article  CAS  Google Scholar 

  18. Schatzberg AF, Nemeroff CB (eds), Textbook of Psychopharmacology, 2nd edn, American Psychiatric Press: Washington, DC, 1998.

    Google Scholar 

  19. Stearns V, Isaac C, Rowland J, Crawford J, Ellis MJ, Kramer R et al. A pilot trial assessing the efficacy of peroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors. Ann Oncol 2000; 11: 17–22.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Showa University, Tokyo, Japan

    M Naoe, Y Ogawa, T Shichijo, K Fuji, T Fukagai & H Yoshida

Authors
  1. M Naoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Shichijo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Fuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Fukagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Naoe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naoe, M., Ogawa, Y., Shichijo, T. et al. Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer. Prostate Cancer Prostatic Dis 9, 275–278 (2006). https://doi.org/10.1038/sj.pcan.4500891

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500891

Keywords

This article is cited by

Search

Advanced search

Quick links